Search Results - "Todd, Kennedi"
-
1
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations
Published in The Journal of experimental medicine (05-02-2024)“…Aducanumab, an anti-amyloid immunotherapy for Alzheimer's disease, efficiently reduces Aβ, though its plaque clearance mechanisms, long-term effects, and…”
Get full text
Journal Article -
2
Commonly disrupted pathways in brain and kidney in a pig model of systemic endotoxemia
Published in Journal of neuroinflammation (04-01-2024)“…Sepsis is a life-threatening state that arises due to a hyperactive inflammatory response stimulated by infection and rarely other insults (e.g.,…”
Get full text
Journal Article -
3
Widespread choroid plexus contamination in sampling and profiling of brain tissue
Published in Molecular psychiatry (01-03-2022)“…The choroid plexus, a tissue responsible for producing cerebrospinal fluid, is found predominantly in the lateral and fourth ventricles of the brain. This…”
Get full text
Journal Article -
4
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma
Published in Blood cancer discovery (08-01-2024)“…Multiple myeloma (MM) is a malignancy that is often driven by MYC and that is sustained by IRF4, which are upregulated by super-enhancers. IKZF1 and IKZF3 bind…”
Get full text
Journal Article -
5
Abstract 5630: Anti-BCMA bispecific tool therapy against VkMYC multiple myeloma is enhanced by IMiDs
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract BCMA is an ideal target antigen for myeloma immunotherapy as it is specifically expressed by plasma cells and T cell-engaging, BCMA-bispecific…”
Get full text
Journal Article -
6
Regulation of meningeal lymphatic function by APOE
Published in Alzheimer's & dementia (01-12-2023)“…Background The meningeal layers form a unique interface between the central nervous and peripheral immune systems. The lymphatic vasculature that is present in…”
Get full text
Journal Article -
7
IMiDs Synergize with EP300 Inhibition to Disrupt the Ikzf/MYC/IRF4 Axis in Multiple Myeloma
Published in Blood (15-11-2022)Get full text
Journal Article -
8
Disrupting Ectopic Super-Enhancers to Treat Multiple Myeloma
Published in Blood (23-11-2021)“…Multiple myeloma (MM) is an incurable form of plasma cell cancer in which primary and secondary chromosomal translocations routinely juxtapose oncogenes to…”
Get full text
Journal Article -
9
P-177 Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma (MM)
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article